Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,719 | -22,122 | -35,584 | -24,080 | -15,687 |
| Depreciation Amortization | 43 | 17 | -85 | -90 | -77 |
| Accounts receivable | -4,220 | -1,144 | N/A | 579 | N/A |
| Accounts payable and accrued liabilities | -219 | 583 | 1,914 | 533 | 319 |
| Other Working Capital | -3,927 | 31 | -240 | 222 | -1,675 |
| Other Operating Activity | 7,041 | 4,301 | -3,988 | -2,267 | -2,096 |
| Operating Cash Flow | $-37,001 | $-18,334 | $-37,983 | $-25,103 | $-19,216 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -28,195 | N/A | 18,067 | -10,933 | -7,739 |
| PPE Investments | N/A | N/A | -363 | -219 | -100 |
| Investing Cash Flow | $-28,195 | $N/A | $17,704 | $-11,152 | $-7,839 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | 20,000 | 5,329 | 5,329 | N/A |
| Debt Repayment | N/A | N/A | -6,497 | -6,497 | -4,833 |
| Common Stock Issued | 58,255 | 58,072 | 53,678 | 47,741 | 47,773 |
| Other Financing Activity | -85 | -85 | -255 | -255 | 0 |
| Financing Cash Flow | $78,170 | $77,987 | $52,255 | $46,318 | $42,940 |
| Beginning Cash Position | 61,761 | 61,761 | 29,785 | 29,785 | 29,785 |
| End Cash Position | 74,735 | 121,414 | 61,761 | 39,848 | 45,670 |
| Net Cash Flow | $12,974 | $59,653 | $31,976 | $10,063 | $15,885 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,001 | -18,334 | -37,983 | -25,103 | -19,216 |
| Capital Expenditure | N/A | N/A | -363 | -219 | -100 |
| Free Cash Flow | -37,001 | -18,334 | -38,346 | -25,322 | -19,316 |